POPULATION PHARMACOKINETICS OF DARBEPOETIN ALFA IN PERITONEAL DIALYSIS AND NON-DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE AFTER SINGLE SUBCUTANEOUS ADMINISTRATION: 10


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles